Vertex Abandons Cystic Fibrosis Combo Trial

Boston-based biotech Vertex Pharmaceuticals will end a late-stage clinical study testing a two-drug combination therapy on cystic fibrosis patients after an independent board concluded the treatment wasn ’t showing meaningful benefit.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news